,25 Recent clinical trials utilizing allotopic gene expression to replace the mutant ND4 gene in LHON patients carrying the m.11778G>A mtDNA mutation demonstrated significant bilateral visual improvements, further highlighting the potential of gene therapy as a promising treatment option for the inherited optic neuropathies.27 This evidence concerns the gene MT-ND4 and Optic neuropathy.